NEW YORK, Jan 7—Celera Genomics has appointed David Block as executive vice president and chief operating officer of its therapeutics division, the company said on Monday. Block starts his new job on Feb. 1.
Registering provides access to this and other free content.
Already have an account?Login Now.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.